: Raised to Strong Buy by HC Wainwright .
: Rating increased to Strong Buy at Truist Financial. strong buy biotech stocks
Several biotechnology companies have recently earned ratings from analysts as of April 28, 2026. These ratings are often driven by positive clinical trial progress, strategic acquisitions, or analyst upgrades following strong performance. Latest Analyst "Strong Buy" Upgrades : Raised to Strong Buy by HC Wainwright